AU2001296014A1 - Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue - Google Patents

Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue

Info

Publication number
AU2001296014A1
AU2001296014A1 AU2001296014A AU9601401A AU2001296014A1 AU 2001296014 A1 AU2001296014 A1 AU 2001296014A1 AU 2001296014 A AU2001296014 A AU 2001296014A AU 9601401 A AU9601401 A AU 9601401A AU 2001296014 A1 AU2001296014 A1 AU 2001296014A1
Authority
AU
Australia
Prior art keywords
recoverying
preventing fatigue
foods
agents
central nerve
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001296014A
Inventor
A.Eric Newsholme
Takanobu Yamamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Meiji Dairies Corp
Original Assignee
Meiji Dairies Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Meiji Dairies Corp filed Critical Meiji Dairies Corp
Publication of AU2001296014A1 publication Critical patent/AU2001296014A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17Amino acids, peptides or proteins
    • A23L33/175Amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/196Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Mycology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001296014A 2000-10-27 2001-10-26 Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue Abandoned AU2001296014A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP2000329409 2000-10-27
JP2000-329409 2000-10-27
JP2001118710 2001-04-17
JP2001-118710 2001-04-17
PCT/JP2001/009439 WO2002034257A1 (en) 2000-10-27 2001-10-26 Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue

Publications (1)

Publication Number Publication Date
AU2001296014A1 true AU2001296014A1 (en) 2002-05-06

Family

ID=26602970

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001296014A Abandoned AU2001296014A1 (en) 2000-10-27 2001-10-26 Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue

Country Status (5)

Country Link
US (1) US20040033252A1 (en)
JP (1) JPWO2002034257A1 (en)
AU (1) AU2001296014A1 (en)
CA (1) CA2427030C (en)
WO (1) WO2002034257A1 (en)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2004123564A (en) * 2002-09-30 2004-04-22 Inst Of Physical & Chemical Res Amino acid composition for improving central neural function
RU2372900C2 (en) * 2004-07-14 2009-11-20 Адзиномото Ко., Инк. Inhibitor of contraction and development of liver cancer to be applied in hepatitis c positive patients suffering from cirrhosis
US8420602B2 (en) * 2004-09-14 2013-04-16 Landon C. G. Miller Endocannabinoid conjugate and a pharmaceutical composition for treatment of neuronal disorders
US7074775B2 (en) 2004-09-14 2006-07-11 Miller Landon C G Aminobutyramide conjugate and a pharmaceutical composition for treatment of neuronal disorders
WO2006080087A1 (en) * 2005-01-31 2006-08-03 Takanobu Yamamoto Method of screening antistress substance and antistress agent
JP5604673B2 (en) * 2005-01-31 2014-10-15 隆宣 山本 Composition for recovery or prevention of fatigue of central nervous system
US20060210515A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Hair growth formula
US7749545B2 (en) 2005-03-18 2010-07-06 Sakura Properties, Llc Fucoidan compositions and methods for dietary and nutritional supplements
US20060210524A1 (en) * 2005-03-18 2006-09-21 Mower Thomas E Skin care composition
JPWO2006137469A1 (en) * 2005-06-22 2009-01-22 味の素株式会社 Metabotropic glutamate receptor activator
WO2007084752A2 (en) * 2006-01-19 2007-07-26 Sakura Properties, Llc Sports drink concentrate and dehydrated powder
KR101451438B1 (en) 2006-03-15 2014-10-15 산토리 홀딩스 가부시키가이샤 Composition containing riboflavin and sesamins
WO2007140022A2 (en) * 2006-06-01 2007-12-06 Sakura Properties, Llc Fucoidan compositions and methods
JP4163727B2 (en) * 2006-08-31 2008-10-08 本田技研工業株式会社 Oil level detection device for internal combustion engine
TWI397418B (en) 2006-10-10 2013-06-01 Otsuka Pharma Co Ltd Anti-depression drug
NZ579189A (en) 2007-02-28 2012-03-30 Meiji Co Ltd Casein amino acid mixture composition for promoting fat burning, improving endurance, reducing fatigue, supporting recovery from fatigue, obesity resistance and stress resistance
EP2135606B1 (en) * 2007-03-15 2018-01-24 Suntory Holdings Limited Anti-fatigue agent
AU2008319747B2 (en) 2007-10-31 2013-04-18 Meiji Co., Ltd. Anti-fatigue agent comprising amino acid composition
US20090186098A1 (en) * 2008-01-18 2009-07-23 Jose Briceno Sports drink composition
JP5866138B2 (en) * 2010-10-28 2016-02-17 幸雄 米田 Osteoporosis preventive and / or therapeutic agent, bone resorption inhibitor, osteogenesis promoter and screening method thereof
KR102549896B1 (en) 2017-01-12 2023-07-03 미쯔비시 가스 케미칼 컴파니, 인코포레이티드 Capsule containing pyrroloquinolinequinone or a salt thereof and branched-chain amino acids

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1212792B (en) * 1983-11-30 1989-11-30 Egidio Aldo Moja DIETARY SUPPLEMENT AND PRE-PACKED FOOD THAT CONTAINS IT PREPARATION PROCEDURE AND METHOD OF ADMINISTRATION
US5284774A (en) * 1987-02-24 1994-02-08 The United States Of America As Represented By The Secy. Of The Dept. Of Health & Human Resources Antineoplastic, system-L specific amino acid nitrogen mustards
JPH0336833A (en) * 1989-07-04 1991-02-18 Fujitsu Ltd Evaluation function arithmetic circuit
EP0873754B1 (en) * 1996-01-09 2003-07-30 Riken Amino acid compositions
JPH11304793A (en) * 1998-04-27 1999-11-05 Taisho Pharmaceut Co Ltd Method for evaluating mental fatigue refreshing substance
JP2000026290A (en) * 1998-07-07 2000-01-25 Crescendo Corporation:Kk Maintenance of muscular strength with branched chain amino acid

Also Published As

Publication number Publication date
CA2427030C (en) 2010-06-01
JPWO2002034257A1 (en) 2004-03-04
US20040033252A1 (en) 2004-02-19
CA2427030A1 (en) 2003-04-25
WO2002034257A1 (en) 2002-05-02

Similar Documents

Publication Publication Date Title
AU2001296014A1 (en) Agents for recoverying from or preventing fatigue in the central nerve system and foods for recoverying from or preventing fatigue
AU5567698A (en) Device for use in the eye
AU6503299A (en) High-beta-conglycinin products and their use
AU2001231048A1 (en) System for trading commodities and the like
AU2001245384A1 (en) Delivery system and method for vehicles and the like
PL339332A1 (en) Assembly member in particular that for use on furniture
AU3548099A (en) Progression elevated gene-3 and uses thereof
ZA991946B (en) Pyrazolopyrimidines and pyrazolotriazines.
AU2002243246A1 (en) Cddo-compounds and combination therapies thereof
AU2001253733A1 (en) Video-monitoring safety systems and methods
AU7597898A (en) Use of isoflavonoids in the treatment or prevention of postpartum depression
AU2002217045A1 (en) Method and arrangement for optically stimulating the visual system
AU4900797A (en) Conformationally restricted polyamines and their use as antineoplastic agents
AU2841801A (en) Triazolotriazinones and the use thereof
ZA988529B (en) Synergistic herbicidal methods and compositions.
GB2370233B (en) Apparatus for use in behaviour modification and the like
AU2001264852A1 (en) Lactobacillusbeta -glucuronidase and dna encoding the same
TW360156U (en) Check valve and valve member for the check valve
AU5572700A (en) Valve unit and container
AU6494298A (en) Valve arrangement and valve for the same
AU6819598A (en) Anti-counterfeit method and product using the method
AU2001273691A1 (en) Integrated decontamination and characterization system and method
AU2001292368A1 (en) Antiobestic agents and health foods
GB0009204D0 (en) Headstones and the like
AU8203798A (en) Grasping member for excavator, excavator and use thereof various especially in sylviculture